Actively Recruiting
Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Led by Tanta University · Updated on 2024-07-08
150
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of this prospective randomized controlled study is to compare safety and efficacy of Vardenafil versus Tadalafil versus Tamsulosin in terms of (voiding function, sexual function and quality of life) in the management of moderate BPH related LUTS.
CONDITIONS
Official Title
Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Sexually active men
- Moderate benign prostatic hyperplasia related lower urinary tract symptoms with an International Prostate Symptom Score between 8 and 19
- Patients who accepted medical treatment and completed 12 weeks of treatment with strict follow-up
You will not qualify if you...
- Need for combined therapy due to prostate size over 40 grams
- Presence of gross hematuria
- Refractory urinary retention
- Bilateral hydro-ureteronephrosis or kidney problems caused by benign prostatic hyperplasia
- Bladder diverticula or bladder stones
- History of bladder or prostate cancer
- Unwillingness to receive medical therapy
- History of pelvic surgery or urethral stricture
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculity of medicine - Tanta university
Tanta, Gharbia Governorate, Egypt, 31528
Actively Recruiting
Research Team
H
Hazem B. Baz, M.B.B.Ch
CONTACT
M
Mohamed G. Soliman, M.D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here